Japan· JP-6111400D3051
ベンジルペニシリンカリウム
A benzylpenicillin product containing ベンジルペニシリンカリウム, registered in Japan by Ｍｅｉｊｉ Ｓｅｉｋａ ファルマ, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Benzylpenicillin is registered in 13 of 19 countries.
Countries holding a registration under ATC J01CE01 (benzylpenicillin), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 6 of them publish a price we can compare per daily dose
Benzylpenicillin · ATC J01CE01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ベンジルペニシリンカリウム
- Manufacturer
- Ｍｅｉｊｉ Ｓｅｉｋａ ファルマ
- Country
- Japan (JP)
- ATC code
- J01CE01
- ATC class
- Benzylpenicillin
- Defined daily dose
- 3.6 g, P
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
30 interactions on record for benzylpenicillin.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Benzylpenicillin · interactions on record
30 records
- 3 severe
- 18 moderate
- 4 minor
- 5 info
Most severe, free to view
- MethotrexateL01BA01severe
- MethotrexateL04AX03severe
- MethotrexatM01CX01severe
- Sodium picosulfateA06AB08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01CE01
Benzylpenicillin, as other registers publish it.
- FinlandBensylpenicillin NoridemNoridem Enterprises Limited
- FinlandBensylpenicillin NoridemNoridem Enterprises Limited
- FinlandBensylpenicillin NoridemNoridem Enterprises Limited
- FinlandBensylpenicillin NoridemNoridem Enterprises Limited
- DenmarkBenzylpenicillin "Fresenius Kabi"Fresenius Kabi AB
- DenmarkBenzylpenicillin "Fresenius Kabi"Fresenius Kabi AB
- DenmarkBenzylpenicillin "Fresenius Kabi"Fresenius Kabi AB
- DenmarkBenzylpenicillin "Fresenius Kabi"Fresenius Kabi AB
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dbc064c6-c00b-437e-a86c-0b1b9e3d1cde GET /v1/drugs/dbc064c6-c00b-437e-a86c-0b1b9e3d1cde?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１００万単位１瓶",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "6111400D3051",
"category": "注射薬",
"price_yen": 485,
"generic_name": "ベンジルペニシリンカリウム",
"product_name_jp": null,
"therapeutic_class": "6111",
"transitional_expiry": null
}See everything about benzylpenicillin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.